What is Multiple Myeloma?

Multiple myeloma is a form of cancer that affects the bone marrow. The cancer is also called Kahler’s disease, named after an Austrian pathologist called Otto Kahler who first described the condition.

The bone marrow is the spongy soft tissue that lies within the hollow centre of some bones. The bone marrow contains stem cells that produce three forms of blood cells: the red blood cells (RBCs) that transport oxygen to cells in the body; the white blood cells (WBCs) involved in fighting infection; and platelets which are essential for blood clotting and healing processes.

In multiple myeloma, the plasma cells or plasmocytes which secrete antibodies become abnormal and are produced in large numbers. These abnormal plasma cells or myeloma cells produce large amounts of an abnormal antibody (immunoglobulin) called paraprotein or M protein. This abnormal immunoglobulin is not effective at fighting infection and also interferes with the production of normal immunoglobulins.


Myeloma does not form a lump or tumour as the myeloma cells proliferate and spread throughout the bone marrow. This eventually damages the bone and causes it to become thin, painful and prone to fracture.

The disease is called multiple myeloma because it effects various sites in the body. Some examples of the areas that may be affected include:

  • The spine
  • The skull
  • The pelvis
  • Areas around the hips and shoulders
  • The legs and arms

In the early stages of disease, few or no symptoms may be present and the condition is often only suspected or detected following routine blood or urine tests. As the condition progresses, however, symptoms such as fatigue, weight loss, bone pain and susceptibility to bone fracture eventually manifest.


Diagnosis is usually based on blood test results that indicate abnormally high levels of proteins and the presence of cancer cells. Urine is checked for the presence of the abnormal proteins produced by myeloma cells. These proteins can damage the kidneys and a urine test can indicate the level of the proteins present as well as showing how well the kidneys are working. A bone marrow biopsy is usually performed to confirm a diagnosis and usually involves a small bone sample being removed from a patient’s pelvis.


Multiple myeloma is not usually curable and treatment is therefore aimed at delaying the progression of the cancer for as long as possible. Treatment primarily involves anti-myeloma treatments to remove the abnormal cells from the bone marrow, relieving any symptoms such as anemia and bone pain, and minimizing the risk of fracture by using treatment to protect the bones.

Further Reading

Last Updated: Feb 27, 2019

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2019, February 27). What is Multiple Myeloma?. News-Medical. Retrieved on October 03, 2022 from https://www.news-medical.net/health/What-is-Multiple-Myeloma.aspx.

  • MLA

    Mandal, Ananya. "What is Multiple Myeloma?". News-Medical. 03 October 2022. <https://www.news-medical.net/health/What-is-Multiple-Myeloma.aspx>.

  • Chicago

    Mandal, Ananya. "What is Multiple Myeloma?". News-Medical. https://www.news-medical.net/health/What-is-Multiple-Myeloma.aspx. (accessed October 03, 2022).

  • Harvard

    Mandal, Ananya. 2019. What is Multiple Myeloma?. News-Medical, viewed 03 October 2022, https://www.news-medical.net/health/What-is-Multiple-Myeloma.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
How effective is mRNA vaccination in multiple myeloma patients?